Summary: GLP-1 receptor agonists are not licensed for NAFLD treatment in the UK but may reduce liver fat and improve metabolic parameters when prescribed for type 2 diabetes or weight management in eligible patients with concurrent liver disease
Not long after Eng and Raufman discovered exendin-4, Eng began to think about its potential for treating diabetes in a way it had never been treated before
Dawson DW, Hertzer K, Moro A, Donald G, Chang HH, Go VL, et al
[DOI] [PubMed] 68.Rosenstock J, Allison D, Birkenfeld AL, Blicher TM, Deenadayalan S, Jacobsen JB, Serusclat P, Violante R, Watada H, Davies M, PIONEER 3 Investigators
Metabolism and HIV-1 assembly and budding The reliance of HIV-1 assembly and budding on host-cell metabolism is largely related to the viral mRNA and protein synthesis along with the availability of lipids such as cholesterol